Pennsylvania High Court Won’t Hear Appeal Of $2.5M Risperdal Gynecomastia Verdict
PHILADELPHIA — The Pennsylvania Supreme Court on Aug. 2 denied a petition for allowance of appeal by Janssen Pharmaceuticals Inc. of a $2.5 million Risperdal gynecomastia verdict (Phillip Pledger, et al....To view the full article, register now.
Already a subscriber? Click here to view full article